(Press-News.org) Findings from a pair of new studies could speed up the development of a universally accurate diagnostic test for human herpes simplex viruses (HSV), according to researchers at Johns Hopkins and Harvard universities and the National Institutes of Health (NIH). The work may also lead to the development of a vaccine that protects against the virus.
Depending on the strain and other factors, HSV can cause cold sores -- classically associated with HSV1 -- or genital herpes -- classically HSV2 -- with the latter being the more serious of the two diseases, particularly because studies show that HSV2 makes carriers more susceptible to contracting HIV. Currently, individuals are screened for HSV using a test that distinguishes between a glycoprotein -- or a molecule containing a carbohydrate and a protein -- present in HSV1, which is common throughout the population, and the considerably rarer HSV2. Whereas the test discriminates between the two variants with high accuracy in the United States and Europe, it largely fails in Africa, where rates of HIV and HSV are highest.
HSV was first genetically sequenced using only European patient strains, and the resulting diagnostic test was developed to identify sequences common to those strains. Scientists have long suspected that the glycoproteins present in African patients who are HSV-positive might differ from patients in the U.S. and Europe.
"Because HSV2 enhances HIV transmission, we have been testing people across East Africa for genital herpes, but everybody was coming up positive. The test was just not as specific as it should be," says Thomas Quinn, M.D., professor of medicine at the Johns Hopkins University School of Medicine and associate director of international research and senior investigator in the Division of Intramural Research at NIH's National Institute of Allergy and Infectious Diseases.
Quinn, who has been conducting research in East Africa for 30 years, was a senior author on both studies, which will appear in print in the August issue of the Journal of Virology.
To test the possibility that the glycoproteins differ in African patients, Quinn and his colleagues conducted a series of studies, one characterizing the entire HSV2 genome and another focusing on the glycoproteins present in HSV2 compared to HSV1, the target of several vaccines currently in research and development.
The team collected and analyzed 34 HSV2 strains in Uganda, South Africa, Japan and the United States. They also added two South African sequences gathered by David Knipe, a herpes researcher at Harvard University.
In the first published paper, the team reported that compared to HSV1, HSV2 has less genetic diversity. Besides providing clues to how the two strains evolved, the findings also have implications for vaccine development, Quinn says, because HSV2's low genetic diversity means fewer antigens could be enough for developing a globally effective HSV2 vaccine.
In the second paper, the team looked more closely at what might be needed to develop a more universally accurate diagnostic test, Quinn says. Because the current test discriminates between HSV1 and HSV2 by looking at variations in a localized region of so-called glycoprotein G, the team focused on the glycoproteins present in HSV by comparing the 36 HSV2 strains from the first paper to 26 previously sequenced strains of HSV1 and looking at geographic diversity among the HSV2 glycoprotein sequences.
According to Quinn, they found that the African strains of glycoprotein G differed slightly from those in strains from other countries. Glycoproteins I and E also showed some variation.
"That explains why the diagnostic test didn't work optimally in Africa," Quinn says, adding that it should now be possible to develop a more universal screening tool. "From this study, you then can make a consensus sequence that is common across the world for HSV2 glycoprotein that is different for HSV1 so you don't get this misdiagnosis."
INFORMATION:
Other Johns Hopkins researchers involved with these studies include Stuart Ray, M.D., and Aaron Tobian, M.D., Ph.D.
This project has been funded in part with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN272200900018C to the Broad Institute's Genomic Sequencing Center for Infectious Diseases, grant AI057552 to DM Knipe and grants AI 094019 and AI030731 to DM Koelle. This work was also supported by the Division of Intramural Research of the National Institute of Allergy and Infectious Diseases.
Media contacts:
Marin Hedin, 410-502-9429, mhedin2@jhmi.edu,
Helen Jones, 410-502-9422, hjones49@jhmi.edu
WASHINGTON, D.C. - Nutrient-rich water from melting Antarctic glaciers nourishes the ocean food chain, creating feeding "hot spots" in large gaps in the sea ice, according to a new study.
New research finds that iron stored in the region's glaciers is being shuttled by melting water to open areas of the ocean, called polynyas, where it stimulates growth of phytoplankton, ocean algae that form the base of the marine food chain. Krill and fish thrive on phytoplankton, and these smaller animals support penguins, seals and whales that feed and breed in the polynyas that ...
It has been well established that women who have had several abortions or miscarriages are likely to face a slightly higher risk of complications in subsequent pregnancies. They may experience vaginal bleeding during early pregnancy, preterm birth, low fetal birth weight, and placenta-related complications. Women with a medical history of several interrupted pregnancies are usually advised to take extra precautions to ensure healthy full-term pregnancies later in life.
New Tel Aviv University research published in the Journal of Maternal-Fetal and Neonatal Medicine finds ...
CINCINNATI - Researchers at Cincinnati Children's Hospital Medical Center have developed a user-friendly, integrated platform for analyzing the transcriptomic and epigenomic "big data."
Reporting their platform in Genome Biology, scientists say that the new platform--called BioWardrobe--could help biomedical researchers answer questions about both basic biology and disease.
The recent proliferation of next-generation sequencing (NGS)-based methods for analysis of gene expression, chromatin structure and protein-DNA interactions have opened new horizons for molecular ...
Acknowledging key strengths and "lessons learned," preventive cardiologists from Johns Hopkins and Mayo Clinic have developed a short list of suggested upgrades to the controversial heart disease prevention guidelines issued jointly in 2013 by the American Heart Association and the American College of Cardiology.
The recommendations, published in the Aug. 11 issue of Mayo Clinic Proceedings, are designed, the authors say, to improve subsequent guidelines and clarify key points of confusion related to risk prediction and treatment of heart attacks and strokes.
"Given ...
San Antonio -- August 11, 2015 -- The latest data from NASA's New Horizons spacecraft reveal diverse features on Pluto's surface and an atmosphere dominated by nitrogen gas. However, Pluto's small mass allows hundreds of tons of atmospheric nitrogen to escape into space each hour.
So where does all this nitrogen come from? Dr. Kelsi Singer, a postdoctoral researcher at Southwest Research Institute, and her mentor Dr. Alan Stern, SwRI associate vice president and the science lead for the New Horizons mission, outlined likely sources in a paper titled, "On the Provenance ...
New research on monkeys vaccinated against HIV's relative SIV calls into question an idea that has driven AIDS vaccine work for years. The assumption: a protective vaccine only needs to stimulate moderate levels of antibodies that neutralize the virus.
However, scientists at Yerkes National Primate Research Center and the Emory Vaccine Center have found that when SIV manages to infect vaccinated monkeys that have potent neutralizing antibodies in their blood, the virus appears to shrug the antibodies off. No stealthy escape by mutation was necessary.
The results were ...
TORONTO, August 11 2015 -- There can be a difference in how well babies focus attention on an object of interest, depending on whether they were delivered by natural birth or Caesarean section, a recent York University study indicates.
"Our research has revealed that being born by a C-section slows a baby's spatial attention, which plays a role in its ability to focus on a particular area or object of interest," says Professor Scott Adler in the Department of Psychology, Faculty of Health at YorkU.
According to Adler and his co-researcher Audrey Wong Kee-You, very ...
Every day, we expend energy when we control the networks in our lives. For example, to drive our car, we utilize a network whose components include the car's accelerator, steering wheel, and brake. Knowing how much that effort "costs" can help determine which components to manipulate--and to what degree--to ensure the smoothest, safest ride as you acclerate from 55 to 90 miles per hour.
On Monday, Northeastern researchers revealed just such a measuring strategy in a new paper published in Nature Physics.
"We ...
WASHINGTON -- An initiative to better understand how melting ice sheets will contribute to sea-level rise, efforts to decode the genomes of organisms to understand evolutionary adaptations, and a next-generation cosmic microwave background experiment to address fundamental questions about the origin of the universe are the top research goals for Antarctic and Southern Ocean science recommended in a new report from the National Academies of Sciences, Engineering, and Medicine.
The report, which offers a strategic vision to guide the U.S. Antarctic Program at the National ...
Vortioxetine (trade name: Brintellix) has been approved since December 2013 for the treatment of depression in adults, but did not become actually available before May 2015. The German Institute for Quality and Efficiency in Health Care (IQWiG) examined in a dossier assessment whether this drug offers an added benefit over the appropriate comparator therapy. Such an added benefit cannot be derived from the dossier because it contained no data evaluable for the assessment.
SSRI is drug component of comparator therapy
The Federal Joint Committee (G-BA) distinguished between ...
